The response of thrombosis in the portal vein or hepatic vein in hepatocellular carcinoma to radiation therapy
The purpose of current study is to evaluate the response of the patients with portal vein thrombosis (PVT) or hepatic vein thrombosis (HVT) in hepatocellular carcinoma (HCC) treated with three-dimensional conformal radiation therapy (3D-CRT). In addition, survival of patients and potential prognosti...
Saved in:
Published in | Radiation oncology journal Vol. 34; no. 3; pp. 168 - 176 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Korea (South)
The Korean Society for Radiation Oncology
01.09.2016
대한방사선종양학회 |
Subjects | |
Online Access | Get full text |
ISSN | 2234-1900 2234-3156 2234-3164 |
DOI | 10.3857/roj.2016.01669 |
Cover
Abstract | The purpose of current study is to evaluate the response of the patients with portal vein thrombosis (PVT) or hepatic vein thrombosis (HVT) in hepatocellular carcinoma (HCC) treated with three-dimensional conformal radiation therapy (3D-CRT). In addition, survival of patients and potential prognostic factors of the survival was evaluated.
Forty-seven patients with PVT or HVT in HCC, referred to our department for radiotherapy, were retrospectively reviewed. For 3D-CRT plans, a gross tumor volume (GTV) was defined as a hypodense filling defect area in the portal vein (PV) or hepatic vein (HV). Survival of patients, and response to radiation therapy (RT) were analyzed. Potential prognostic factors for survival and response to RT were evaluated.
The median survival time of 47 patients was 8 months, with 1-year survival rate of 15% and response rate of 40%. Changes in Child-Pugh score, response to RT, Eastern cooperative oncology group performance status (ECOG PS), hepatitis C antibody (HCVAb) positivity, and additional post RT treatment were statistically significant prognostic factors for survival in univariate analysis (p = 0.000, p = 0.018, p = 0.000, p = 0.013, and p = 0.047, respectively). Of these factors, changes in Child-Pugh score, and response to RT were significant for patients' prognosis in multivariate analysis (p = 0.001 and p = 0.035, respectively).
RT could constitute a reasonable treatment option for patients with PVT or HVT in HCC with acceptable toxicity. Changes in Child-Pugh score, and response to RT were statistically significant factors of survival of patients. |
---|---|
AbstractList | The purpose of current study is to evaluate the response of the patients with portal vein thrombosis (PVT) or hepatic vein thrombosis (HVT) in hepatocellular carcinoma (HCC) treated with three-dimensional conformal radiation therapy (3D-CRT). In addition, survival of patients and potential prognostic factors of the survival was evaluated.
Forty-seven patients with PVT or HVT in HCC, referred to our department for radiotherapy, were retrospectively reviewed. For 3D-CRT plans, a gross tumor volume (GTV) was defined as a hypodense filling defect area in the portal vein (PV) or hepatic vein (HV). Survival of patients, and response to radiation therapy (RT) were analyzed. Potential prognostic factors for survival and response to RT were evaluated.
The median survival time of 47 patients was 8 months, with 1-year survival rate of 15% and response rate of 40%. Changes in Child-Pugh score, response to RT, Eastern cooperative oncology group performance status (ECOG PS), hepatitis C antibody (HCVAb) positivity, and additional post RT treatment were statistically significant prognostic factors for survival in univariate analysis (p = 0.000, p = 0.018, p = 0.000, p = 0.013, and p = 0.047, respectively). Of these factors, changes in Child-Pugh score, and response to RT were significant for patients' prognosis in multivariate analysis (p = 0.001 and p = 0.035, respectively).
RT could constitute a reasonable treatment option for patients with PVT or HVT in HCC with acceptable toxicity. Changes in Child-Pugh score, and response to RT were statistically significant factors of survival of patients. Purpose: The purpose of current study is to evaluate the response of the patients with portal vein thrombosis (PVT) or hepatic vein thrombosis (HVT) in hepatocellular carcinoma (HCC) treated with three-dimensional conformal radiation therapy (3D-CRT). In addition, survival of patients and potential prognostic factors of the survival was evaluated. Materials and Methods: Forty-seven patients with PVT or HVT in HCC, referred to our department for radiotherapy, were retrospectively reviewed. For 3D-CRT plans, a gross tumor volume (GTV) was defined as a hypodense filling defect area in the portal vein (PV) or hepatic vein (HV). Survival of patients, and response to radiation therapy (RT) were analyzed. Potential prognostic factors for survival and response to RT were evaluated. Results: The median survival time of 47 patients was 8 months, with 1-year survival rate of 15% and response rate of 40%. Changes in Child-Pugh score, response to RT, Eastern cooperative oncology group performance status (ECOG PS), hepatitis C antibody (HCVAb) positivity, and additional post RT treatment were statistically significant prognostic factors for survival in univariate analysis (p = 0.000, p = 0.018, p = 0.000, p = 0.013, and p = 0.047, respectively). Of these factors, changes in Child-Pugh score, and response to RT were significant for patients’ prognosis in multivariate analysis (p = 0.001 and p = 0.035, respectively). Conclusion: RT could constitute a reasonable treatment option for patients with PVT or HVT in HCC with acceptable toxicity. Changes in Child-Pugh score, and response to RT were statistically significant factors of survival of patients. KCI Citation Count: 2 PURPOSEThe purpose of current study is to evaluate the response of the patients with portal vein thrombosis (PVT) or hepatic vein thrombosis (HVT) in hepatocellular carcinoma (HCC) treated with three-dimensional conformal radiation therapy (3D-CRT). In addition, survival of patients and potential prognostic factors of the survival was evaluated.MATERIALS AND METHODSForty-seven patients with PVT or HVT in HCC, referred to our department for radiotherapy, were retrospectively reviewed. For 3D-CRT plans, a gross tumor volume (GTV) was defined as a hypodense filling defect area in the portal vein (PV) or hepatic vein (HV). Survival of patients, and response to radiation therapy (RT) were analyzed. Potential prognostic factors for survival and response to RT were evaluated.RESULTSThe median survival time of 47 patients was 8 months, with 1-year survival rate of 15% and response rate of 40%. Changes in Child-Pugh score, response to RT, Eastern cooperative oncology group performance status (ECOG PS), hepatitis C antibody (HCVAb) positivity, and additional post RT treatment were statistically significant prognostic factors for survival in univariate analysis (p = 0.000, p = 0.018, p = 0.000, p = 0.013, and p = 0.047, respectively). Of these factors, changes in Child-Pugh score, and response to RT were significant for patients' prognosis in multivariate analysis (p = 0.001 and p = 0.035, respectively).CONCLUSIONRT could constitute a reasonable treatment option for patients with PVT or HVT in HCC with acceptable toxicity. Changes in Child-Pugh score, and response to RT were statistically significant factors of survival of patients. |
Author | Kim, Jae-Chul Bae, Bong Kyung |
Author_xml | – sequence: 1 givenname: Bong Kyung surname: Bae fullname: Bae, Bong Kyung – sequence: 2 givenname: Jae-Chul surname: Kim fullname: Kim, Jae-Chul |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27545294$$D View this record in MEDLINE/PubMed https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002148165$$DAccess content in National Research Foundation of Korea (NRF) |
BookMark | eNp1UUlr3DAUFiUlSZNceyw69jJT7ZIvhRCaNBAolOlZaGS5o8SW3CdPIP--sifpBtXC0-N9C-h7g45STgGht5SsuZH6A-T7NSNUretVzSt0yhgXK06lOnp-04aQE3RRyj2pSxGpFDlGJ0xLIVkjTlHa7AKGUMacSsC5w9MO8rDNJRYcU-0CHjNMrsePofYZ8C6Mbor-0Nez9NmHvt_3DrB34GPKg8NTxuDaWMF5EQI3Pp2j153rS7h4rmfo2_WnzdXn1d2Xm9ury7uVF4xPKxOcYS3RyrTSEMpIqzTVTDozb-IZ2_o6MJxpr31DRJC0axnvjBJ627T8DL0_6Cbo7IOPNru41O_ZPoC9_Lq5tUrppuEV-vEAHffbIbQ-pAlcb0eIg4Onhfj3JMVdlXm0kiglJPntNUL-sQ9lskMs83-4FPK-WGq4FMRIPnu9-9Prl8lLHhUgDgAPuRQInfVxWn6wWsfeUmLn5G1N3s7J2yX5Slv_Q3tR_g_hJ85lsTg |
CitedBy_id | crossref_primary_10_1016_j_jceh_2024_102386 crossref_primary_10_1016_j_ctro_2017_04_003 crossref_primary_10_3389_fonc_2022_829708 crossref_primary_10_4143_crt_2017_096 crossref_primary_10_18632_oncotarget_19219 crossref_primary_10_1186_s12885_021_08469_1 crossref_primary_10_2147_CMAR_S296020 crossref_primary_10_1016_j_jceh_2023_03_006 |
Cites_doi | 10.1016/S0360-3016(03)00434-6 10.1002/(SICI)1097-0142(19960601)77:11<2217::AID-CNCR6>3.0.CO;2-M 10.1016/j.ijrobp.2011.03.019 10.1097/00000658-200103000-00012 10.1016/j.radonc.2007.07.005 10.1016/j.ijrobp.2005.12.031 10.1097/00000658-199906000-00005 10.1002/cncr.10694 10.1016/S0360-3016(02)02915-2 10.1016/j.semradonc.2011.05.003 10.1053/j.gastro.2007.04.061 10.1016/0360-3016(91)90171-Y 10.1007/s004320050189 10.1186/1748-717X-9-101 10.1002/hep.510290145 10.1002/cncr.24139 10.1097/00000421-200204000-00019 10.1093/jjco/hys082 10.1093/jjco/hyl006 10.3857/roj.2012.30.3.146 10.1002/cncr.21043 10.3857/roj.2014.32.3.170 10.1016/S0360-3016(02)02846-8 10.1007/s11605-009-0854-2 10.1111/j.1349-7006.2008.00981.x 10.1016/j.ijrobp.2008.06.1486 10.1097/01.coc.0000239147.60196.11 10.1159/000343855 10.1002/hep.24199 10.1016/j.ijrobp.2009.06.092 10.1046/j.1440-1746.2001.02496.x 10.1016/S0167-8140(02)00061-0 |
ContentType | Journal Article |
Copyright | Copyright © 2016 The Korean Society for Radiation Oncology 2016 |
Copyright_xml | – notice: Copyright © 2016 The Korean Society for Radiation Oncology 2016 |
DBID | AAYXX CITATION NPM 7X8 5PM ACYCR |
DOI | 10.3857/roj.2016.01669 |
DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) Korean Citation Index |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 2234-3156 2234-3164 |
EndPage | 176 |
ExternalDocumentID | oai_kci_go_kr_ARTI_667993 PMC5066450 27545294 10_3857_roj_2016_01669 |
Genre | Journal Article |
GroupedDBID | 5-W 8JR 8XY 9ZL AAKDD AAYXX ABDBF ACUHS ADBBV ADRAZ AEGXH ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL CITATION DIK EF. GX1 HYE KQ8 M48 OK1 PGMZT RPM KVFHK NPM 7X8 5PM .UV ACYCR |
ID | FETCH-LOGICAL-c423t-8ea82d0768d580120d671725a8a8a80c22bc5808327c7c904e51fd23f8647b9d3 |
IEDL.DBID | M48 |
ISSN | 2234-1900 |
IngestDate | Tue Nov 21 21:03:56 EST 2023 Thu Aug 21 18:11:18 EDT 2025 Fri Jul 11 02:10:53 EDT 2025 Thu Jan 02 22:19:49 EST 2025 Thu Apr 24 22:52:10 EDT 2025 Tue Jul 01 01:32:53 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | Hepatocellular carcinoma Portal vein Radiotherapy Hepatic vein |
Language | English |
License | This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c423t-8ea82d0768d580120d671725a8a8a80c22bc5808327c7c904e51fd23f8647b9d3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 G704-000881.2016.34.3.001 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3857/roj.2016.01669 |
PMID | 27545294 |
PQID | 1835408533 |
PQPubID | 23479 |
PageCount | 9 |
ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_667993 pubmedcentral_primary_oai_pubmedcentral_nih_gov_5066450 proquest_miscellaneous_1835408533 pubmed_primary_27545294 crossref_citationtrail_10_3857_roj_2016_01669 crossref_primary_10_3857_roj_2016_01669 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2016-09-01 |
PublicationDateYYYYMMDD | 2016-09-01 |
PublicationDate_xml | – month: 09 year: 2016 text: 2016-09-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Korea (South) |
PublicationPlace_xml | – name: Korea (South) |
PublicationTitle | Radiation oncology journal |
PublicationTitleAlternate | Radiat Oncol J |
PublicationYear | 2016 |
Publisher | The Korean Society for Radiation Oncology 대한방사선종양학회 |
Publisher_xml | – name: The Korean Society for Radiation Oncology – name: 대한방사선종양학회 |
References | ref13 ref12 ref15 ref14 ref31 ref30 ref11 ref10 ref32 ref2 ref1 ref17 ref16 ref19 ref18 ref24 ref23 ref26 ref25 ref20 ref22 ref21 ref28 ref27 ref29 ref8 ref7 ref9 ref4 ref3 ref6 ref5 15822130 - Cancer. 2005 Jun 1;103(11):2419-26 22689916 - Jpn J Clin Oncol. 2012 Aug;42(8):721-9 19296182 - J Gastrointest Surg. 2009 Jun;13(6):1078-83 17716760 - Radiother Oncol. 2007 Sep;84(3):266-71 18760547 - Int J Radiat Oncol Biol Phys. 2009 Mar 15;73(4):1155-63 12065102 - Radiother Oncol. 2002 Apr;63(1):41-5 16613896 - Jpn J Clin Oncol. 2006 Apr;36(4):212-7 11422619 - J Gastroenterol Hepatol. 2001 Jun;16(6):660-5 24804174 - Liver Cancer. 2014 Mar;3(1):18-30 11943901 - Am J Clin Oncol. 2002 Apr;25(2):189-93 9719503 - J Cancer Res Clin Oncol. 1998;124(7):397-400 2032882 - Int J Radiat Oncol Biol Phys. 1991 May 15;21(1):109-22 16690430 - Int J Radiat Oncol Biol Phys. 2006 Jun 1;65(2):426-34 8635087 - Cancer. 1996 Jun 1;77(11):2217-22 21939854 - Semin Radiat Oncol. 2011 Oct;21(4):256-63 12182986 - Int J Radiat Oncol Biol Phys. 2002 Sep 1;54(1):156-62 21374666 - Hepatology. 2011 Mar;53(3):1020-2 19156918 - Cancer. 2009 Mar 15;115(6):1245-52 9862851 - Hepatology. 1999 Jan;29(1):62-7 25324989 - Radiat Oncol J. 2014 Sep;32(3):170-8 19032365 - Cancer Sci. 2008 Dec;99(12):2510-7 11224626 - Ann Surg. 2001 Mar;233(3):379-84 10363892 - Ann Surg. 1999 Jun;229(6):790-9; discussion 799-800 12909223 - Int J Radiat Oncol Biol Phys. 2003 Sep 1;57(1):113-9 17570226 - Gastroenterology. 2007 Jun;132(7):2557-76 17148993 - Am J Clin Oncol. 2006 Dec;29(6):568-75 23170294 - Radiat Oncol J. 2012 Sep;30(3):146-51 12095546 - Int J Radiat Oncol Biol Phys. 2002 Jul 15;53(4):810-21 21621346 - Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):2004-11 20171524 - Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3 Suppl):S94-100 24779518 - Radiat Oncol. 2014 Apr 29;9:101 12209752 - Cancer. 2002 Aug 1;95(3):588-95 |
References_xml | – ident: ref26 doi: 10.1016/S0360-3016(03)00434-6 – ident: ref2 doi: 10.1002/(SICI)1097-0142(19960601)77:11<2217::AID-CNCR6>3.0.CO;2-M – ident: ref17 doi: 10.1016/j.ijrobp.2011.03.019 – ident: ref6 doi: 10.1097/00000658-200103000-00012 – ident: ref27 doi: 10.1016/j.radonc.2007.07.005 – ident: ref23 doi: 10.1016/j.ijrobp.2005.12.031 – ident: ref4 doi: 10.1097/00000658-199906000-00005 – ident: ref7 doi: 10.1002/cncr.10694 – ident: ref20 doi: 10.1016/S0360-3016(02)02915-2 – ident: ref30 doi: 10.1016/j.semradonc.2011.05.003 – ident: ref1 doi: 10.1053/j.gastro.2007.04.061 – ident: ref31 doi: 10.1016/0360-3016(91)90171-Y – ident: ref3 doi: 10.1007/s004320050189 – ident: ref24 doi: 10.1186/1748-717X-9-101 – ident: ref10 doi: 10.1002/hep.510290145 – ident: ref15 doi: 10.1002/cncr.24139 – ident: ref28 doi: 10.1097/00000421-200204000-00019 – ident: ref16 doi: 10.1093/jjco/hys082 – ident: ref29 doi: 10.1093/jjco/hyl006 – ident: ref14 doi: 10.3857/roj.2012.30.3.146 – ident: ref5 doi: 10.1002/cncr.21043 – ident: ref18 doi: 10.3857/roj.2014.32.3.170 – ident: ref22 doi: 10.1016/S0360-3016(02)02846-8 – ident: ref8 doi: 10.1007/s11605-009-0854-2 – ident: ref12 doi: 10.1111/j.1349-7006.2008.00981.x – ident: ref13 doi: 10.1016/j.ijrobp.2008.06.1486 – ident: ref11 doi: 10.1097/01.coc.0000239147.60196.11 – ident: ref9 doi: 10.1159/000343855 – ident: ref19 doi: 10.1002/hep.24199 – ident: ref32 doi: 10.1016/j.ijrobp.2009.06.092 – ident: ref25 doi: 10.1046/j.1440-1746.2001.02496.x – ident: ref21 doi: 10.1016/S0167-8140(02)00061-0 – reference: 10363892 - Ann Surg. 1999 Jun;229(6):790-9; discussion 799-800 – reference: 19296182 - J Gastrointest Surg. 2009 Jun;13(6):1078-83 – reference: 19156918 - Cancer. 2009 Mar 15;115(6):1245-52 – reference: 16690430 - Int J Radiat Oncol Biol Phys. 2006 Jun 1;65(2):426-34 – reference: 20171524 - Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3 Suppl):S94-100 – reference: 12182986 - Int J Radiat Oncol Biol Phys. 2002 Sep 1;54(1):156-62 – reference: 12065102 - Radiother Oncol. 2002 Apr;63(1):41-5 – reference: 2032882 - Int J Radiat Oncol Biol Phys. 1991 May 15;21(1):109-22 – reference: 16613896 - Jpn J Clin Oncol. 2006 Apr;36(4):212-7 – reference: 24779518 - Radiat Oncol. 2014 Apr 29;9:101 – reference: 22689916 - Jpn J Clin Oncol. 2012 Aug;42(8):721-9 – reference: 17716760 - Radiother Oncol. 2007 Sep;84(3):266-71 – reference: 12909223 - Int J Radiat Oncol Biol Phys. 2003 Sep 1;57(1):113-9 – reference: 11943901 - Am J Clin Oncol. 2002 Apr;25(2):189-93 – reference: 18760547 - Int J Radiat Oncol Biol Phys. 2009 Mar 15;73(4):1155-63 – reference: 15822130 - Cancer. 2005 Jun 1;103(11):2419-26 – reference: 23170294 - Radiat Oncol J. 2012 Sep;30(3):146-51 – reference: 21939854 - Semin Radiat Oncol. 2011 Oct;21(4):256-63 – reference: 12095546 - Int J Radiat Oncol Biol Phys. 2002 Jul 15;53(4):810-21 – reference: 9862851 - Hepatology. 1999 Jan;29(1):62-7 – reference: 11224626 - Ann Surg. 2001 Mar;233(3):379-84 – reference: 17148993 - Am J Clin Oncol. 2006 Dec;29(6):568-75 – reference: 21374666 - Hepatology. 2011 Mar;53(3):1020-2 – reference: 17570226 - Gastroenterology. 2007 Jun;132(7):2557-76 – reference: 12209752 - Cancer. 2002 Aug 1;95(3):588-95 – reference: 25324989 - Radiat Oncol J. 2014 Sep;32(3):170-8 – reference: 9719503 - J Cancer Res Clin Oncol. 1998;124(7):397-400 – reference: 24804174 - Liver Cancer. 2014 Mar;3(1):18-30 – reference: 21621346 - Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):2004-11 – reference: 11422619 - J Gastroenterol Hepatol. 2001 Jun;16(6):660-5 – reference: 19032365 - Cancer Sci. 2008 Dec;99(12):2510-7 – reference: 8635087 - Cancer. 1996 Jun 1;77(11):2217-22 |
SSID | ssj0000605660 |
Score | 2.0714374 |
Snippet | The purpose of current study is to evaluate the response of the patients with portal vein thrombosis (PVT) or hepatic vein thrombosis (HVT) in hepatocellular... PURPOSEThe purpose of current study is to evaluate the response of the patients with portal vein thrombosis (PVT) or hepatic vein thrombosis (HVT) in... Purpose: The purpose of current study is to evaluate the response of the patients with portal vein thrombosis (PVT) or hepatic vein thrombosis (HVT) in... |
SourceID | nrf pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 168 |
SubjectTerms | Original 방사선과학 |
Title | The response of thrombosis in the portal vein or hepatic vein in hepatocellular carcinoma to radiation therapy |
URI | https://www.ncbi.nlm.nih.gov/pubmed/27545294 https://www.proquest.com/docview/1835408533 https://pubmed.ncbi.nlm.nih.gov/PMC5066450 https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002148165 |
Volume | 34 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Radiation oncology journal , 2016, 34(3), , pp.168-176 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1NT9wwELUKvXBBVC2wpUWuVImTUT5sxzlUVVUV0Ur01JW4WY7twAJr0-yC4N93Js5uu9VyQUkUWZnEip-dmeeMZwj5yI21tZI5K8rSMc5NzYysHMtcYWTupG8qXDt89lOejvmPc3H-1_9paMDZWmqH-aTG3c3xw-_HzzDgPyHjVEDou3iFPlryGA5Zb5CXoJUkErGzwdRPX2VQ9f2iYVCInIEezFIMxzWPwAjBFSbfrvmKutoIXbvOEv3fofIfDXWyQ7YH05J-SX3hFXnhw2sSoB_QLjnCehpbinkRpk2cTWZ0EqDkaXp5eu-hHDt66dHJ2qYy7H054gQ_eqxSi8mHQpwaOo-0w8gGCC1N67ge35DxybdfX0_ZkGOBWTCk5kx5owqHv-OcQGWVOQkErxBG4ZbZomgsXIBxX9nK1hn3Im9dUbZK8qqpXblLNkMMfp9QrniuatnWmehpIfBTo2zpnBFWeaFGhC2aUtshADnmwbjRQEQQBQ0oaERB9yiMyNFS_jaF3nhS8gMgo6_tRGO0bDxfRH3daeAE37WUFRhhILPATcMIwlYzwce7mc77uS8wW0BmL-G4rG_RDUakWkF4KYD1rV4Jk8s-SrcAY46L7O2z7zwgW_CKPPmlvSOb8-7OvwcLaN4c9l37sJ-a-gNEowXd |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+response+of+thrombosis+in+the+portal+vein+or+hepatic+vein+in+hepatocellular+carcinoma+to+radiation+therapy&rft.jtitle=Radiation+oncology+journal&rft.au=Bae%2C+Bong+Kyung&rft.au=Kim%2C+Jae-Chul&rft.date=2016-09-01&rft.pub=The+Korean+Society+for+Radiation+Oncology&rft.issn=2234-1900&rft.eissn=2234-3164&rft.volume=34&rft.issue=3&rft.spage=168&rft.epage=176&rft_id=info:doi/10.3857%2Froj.2016.01669&rft_id=info%3Apmid%2F27545294&rft.externalDocID=PMC5066450 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2234-1900&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2234-1900&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2234-1900&client=summon |